ChemoCentryx, Inc.
CXCR7 INHIBITORS FOR THE TREATMENT OF CANCER
Last updated:
Abstract:
Provided herein are methods of treating cancer in an individual in need thereof, the methods comprising administering to the individual a CXCR7 inhibitor. In some embodiments, additional therapeutic agents are used. Also provided herein are methods of preventing precancerous cells expressing FRS2.beta. from developing into cancer, the method comprising administering to an individual having precancerous cells expressing FRS2.beta. a CXCR7 inhibitor. In some embodiments, additional therapeutic agents are used.
Status:
Application
Type:
Utility
Filling date:
11 Dec 2019
Issue date:
18 Jun 2020